Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Inflammatory Bowel Diseases

Free Subscription 06.04.2026 4 Aliment Pharmacol Ther 2 Am J Gastroenterol 3 BMC Gastroenterol 1 Clin Gastroenterol Hepatol 4 Dig Dis Sci 2 Dis Colon Rectum 1 Gastroenterology 3 Inflamm Bowel Dis 2 J Crohns Colitis 1 J Pediatr 1 Minerva Gastroenterol (Torino) 1 PLoS One 2 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. HEGDE Y, Caldera F
   Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease - Expanding Strategies Beyond Double-Dose Recombinant Vaccination.
   Aliment Pharmacol Ther. 2026 Mar 31. doi: 10.1111/apt.70651.
   PubMed        
   
   
2. JIAO L, Cao Y
   Letter: Are All Extra-Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story?
   Aliment Pharmacol Ther. 2026 Mar 31. doi: 10.1111/apt.70650.
   PubMed        
   
   
3. BARBERIO B, Savarino EV
   Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity.
   Aliment Pharmacol Ther. 2026 Mar 31. doi: 10.1111/apt.70641.
   PubMed        
   
   
4. ALSOUDANI A, Swaminathan A
   Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease.
   Aliment Pharmacol Ther. 2026 Mar 30. doi: 10.1111/apt.70640.
   PubMed        
   
   

   
   Am J Gastroenterol

5. GOODWIN SW, Vuyyuru SK, Sedano R, Zou G, et al
   An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 Trial.
   Am J Gastroenterol. 2026 Apr 3. doi: 10.14309/ajg.0000000000004015.
   PubMed         Abstract available
   
   
6. GROSS SA, Shaukat A, Afzali A, Ahn JC, et al
   Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus.
   Am J Gastroenterol. 2026;121:1017-1024.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. SOBOLEWSKA-WLODARCZYK A, Orlinski J, Witas Z, Wozniak L, et al
   Real-world utility of platelet count, hemoglobin, and iron levels as predictors of clinical response to vedolizumab in patients with ulcerative colitis: a retrospective, single-center study in Poland.
   BMC Gastroenterol. 2026 Apr 2. doi: 10.1186/s12876-026-04780.
   PubMed        
   
   
8. KIM H, Kim YZ, Kim SY, Choe YH, et al
   Factors associated with low bone mineral density at diagnosis in pediatric Crohn's disease: a large retrospective cohort study.
   BMC Gastroenterol. 2026 Apr 2. doi: 10.1186/s12876-026-04777.
   PubMed        
   
   
9. KAWAKAMI A, Tanaka M, Sakagami K, Ito H, et al
   Factors associated with urgent consultation recommendations for patients with inflammatory bowel disease calling a telephone service about worsening symptoms: a secondary analysis.
   BMC Gastroenterol. 2026 Mar 27. doi: 10.1186/s12876-026-04748.
   PubMed        
   
   

   
   Clin Gastroenterol Hepatol

10. ALLEZ M, Bak MTJ, Brand S, Diebakate-Scordamaglia L, et al
    Development and external validation of a predictive model for postoperative recurrence of Crohn's disease in the biologic era.
    Clin Gastroenterol Hepatol. 2026 Mar 27:S1542-3565(26)00220.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

11. CHEN NY, Chuang CH
    Dosing 5-ASA for Ulcerative Colitis: Is the Maximum Optimum?
    Dig Dis Sci. 2026 Apr 2. doi: 10.1007/s10620-026-09874.
    PubMed        
    
    
12. VADARLIS A, Germanidis G, Maris T, Pramateftakis MG, et al
    Investigating Handgrip Strength as a Practical Biomarker for Therapeutic Endpoints and Nutritional Status in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Apr 1. doi: 10.1007/s10620-026-09880.
    PubMed         Abstract available
    
    
13. COHEN-MEKELBURG S, Hodish G, Ebner D, Resnicow K, et al
    The Multiple Dimensions of Self-Management in Active Inflammatory Bowel Disease: A Qualitative Analysis of Patients' Daily Lived Experiences.
    Dig Dis Sci. 2026 Mar 31. doi: 10.1007/s10620-026-09858.
    PubMed         Abstract available
    
    
14. LEAKE A, Bishara M, Lo SW, Tacey M, et al
    The SILVER Platter for Patients with Inflammatory Bowel Disease (IBD): An IBD Pharmacy Technician-Led Subcutaneous Biologic Home Delivery Service Is Associated with Sustained Improvement in Adherence and Active Health Management.
    Dig Dis Sci. 2026 Mar 27. doi: 10.1007/s10620-026-09785.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

15. PRIEN C, Holubar SD
    Intersphincteric Proctectomy for Fistulizing Perianal Crohn's Disease.
    Dis Colon Rectum. 2026 Apr 1. doi: 10.1097/DCR.0000000000004158.
    PubMed        
    
    
16. ASHBURN JH
    Expert Commentary on Ulcerative Colitis-Associated Neoplasia.
    Dis Colon Rectum. 2026 Mar 27. doi: 10.1097/DCR.0000000000004239.
    PubMed        
    
    

    
    Gastroenterology

17. BURISCH J
    Re-induction or Redirection? Lessons From the REScUE Trial on Ustekinumab Intensification in Crohn's Disease.
    Gastroenterology. 2026 Mar 27:S0016-5085(26)00305.
    PubMed        
    
    

    
    Inflamm Bowel Dis

18. ARZIVIAN A, Rubin DT, Seow CH, Kerkham A, et al
    The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2026;32:661-676.
    PubMed         Abstract available
    
    
19. SINGH S, Oliver BJ, Hou JK, Lum D, et al
    Real-World Implementation of Treat to Target in Patients With IBD in a Learning Health System: An IBD Qorus Collaborative Study.
    Inflamm Bowel Dis. 2026;32:702-710.
    PubMed         Abstract available
    
    
20. WARD TM, Unal E, Kirschling S, Giri B, et al
    Penetrating ileocolic Crohn disease with intra-abdominal abscess: diagnose, drugs, drain, divert?
    Inflamm Bowel Dis. 2026 Mar 31:izag030. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

21. DIMOPOULOS-VERMA A, Kulkarni C, Pike CW, Gombar S, et al
    Statin use is associated with lower rates of stricture development in patients with Crohn's disease: a propensity score-matched study of two nationwide population databases.
    J Crohns Colitis. 2026;20:jjag034.
    PubMed         Abstract available
    
    
22. MOREIRA PL, Dignass A, Estevinho MM, Santiago M, et al
    Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease.
    J Crohns Colitis. 2026;20:jjag030.
    PubMed         Abstract available
    
    

    
    J Pediatr

23. GORDON RJ, Vishwanath V, Lavoie A, Mishra R, et al
    Efficacy and Safety of Titrated High-Dose Cholecalciferol Supplementation in Children and Young Adult Patients with Inflammatory Bowel Disease.
    J Pediatr. 2026 Mar 30:115084. doi: 10.1016/j.jpeds.2026.115084.
    PubMed         Abstract available
    
    

    
    Minerva Gastroenterol (Torino)

24. ZIFMAN E, Schujovitzky D, Galai T
    The effect of hypochlorous acid on urine color among pediatric ulcerative colitis patients treated with mesalamine.
    Minerva Gastroenterol (Torino). 2026 Apr 2. doi: 10.23736/S2724-5985.26.04114.
    PubMed         Abstract available
    
    

    
    PLoS One

25. WEIGEL C, Loosen SH, Yaqubi K, May P, et al
    Twelve?month rehospitalization after IBD?related hospitalization in Germany: A retrospective cohort study using administrative hospital data.
    PLoS One. 2026;21:e0346270.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

26. BERGSMARK C, Kristensen VA, Sjamo MB, Hoivik ML, et al
    Therapeutic drug monitoring in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab: insights from a prospective real-world study.
    Scand J Gastroenterol. 2026 Mar 28:1-11. doi: 10.1080/00365521.2026.2645083.
    PubMed         Abstract available
    
    
27. BUHL E, Kraaer MT, Kjeldsen J, Ainsworth MA, et al
    Personalised treatment in biologically naive patients with Crohn's disease: a systematic review of the last 10 years.
    Scand J Gastroenterol. 2026 Mar 28:1-18. doi: 10.1080/00365521.2026.2645095.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum